Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period.
Lancet Gastroenterol Hepatol
; 5(6): 598-606, 2020 06.
Article
em En
| MEDLINE
| ID: mdl-32305075
The coronavirus disease 2019 (COVID-19) pandemic is changing the management of many chronic diseases, including that of patients with inflammatory bowel diseases (IBD). In particular, the performance of routine endoscopy is temporarily suspended, and only emergency endoscopy is allowed in many countries where severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread. We highlight different scenarios in which endoscopy should still be performed urgently in patients with IBD, as well as recommendations regarding the use of personal protective equipment. We suggest a pathway for performing safe endoscopy and discuss the potential risks of postponing endoscopy in IBD. Finally, we propose a post-pandemic plan for access to endoscopy.
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Pneumonia Viral
/
Doenças Inflamatórias Intestinais
/
Endoscopia do Sistema Digestório
/
Infecções por Coronavirus
Tipo de estudo:
Diagnostic_studies
/
Guideline
Limite:
Humans
Idioma:
En
Revista:
Lancet Gastroenterol Hepatol
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Canadá